Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-06-10

Clinical Trial Update: Verapamil vs Steroid to Prevent Keloid Recurrence [Phase 4]

View source ↗

Summary

A Phase 4 randomized trial comparing verapamil versus a corticosteroid to prevent recurrence of keloid scars was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Corticosteroid (corticosteroid)
  • Verapamil (verapamil)

Snippet

Sponsor: The University of Western Australia | Conditions: Keloid Scars | Phase 4 | Status: TERMINATED